Editions   North America | Europe | Magazine


Pharmaceutical Contract Packaging Market See CAPEX of $47.5 Billion by 2027

Press release from the issuing company

Pharmaceutical Contract Packaging Market (By Product: Primary, Secondary, Tertiary; By Material: Paper & Paperboard, Plastics & Polymers, Aluminium Foil and Others) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook and Segment Forecasts 2020 - 2027

CANADA, Ottawa – Precedence Research has forecasted that the global pharmaceutical contract packaging market will see a capital expenditure (CAPEX) of $47.5 billion by 2027, at a CAGR of 6.8% over the forecast period 2020 to 2027. The pharmaceutical contract packaging market research report offers market estimates for the period 2016 to 2027, wherein 2016 is a historic period, 2020 is the base year, and 2020 to 2027 is the forecast period.

Contract packaging can be a composite or easy process as it is adapted as per explicit scope of the packaging product, which differs significantly across the commercial retail, or trade sectors. Contract packaging and co-packaging players offer contract packaging services to product manufacturers and frequently act as an extension of the organization. Pharmaceutical contract packaging means sub-contracting of secondary operations such as drug labelling and packaging third parties. A contract pharmaceutical packager offers services that include designing drug packing and testing of the packed drug. Foremost pharmaceutical players are now authorizing the operation of packaging of product to those service providers who are skilful and devoted in handling packaging of medicines.

Download FREE SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.precedenceresearch.com/sample/1171

Growth Factors:

Global pharmaceutical industry is shifting at an unparalleled pace. Novel biological treatments for cancer, and a substantial upsurge of prevalent diseases like diabetes generates demand for processing and packaging and solutions to realize the several requirements across the globe. Revolutionary changes are happening in the sector of biological therapies concerning the cancer treatment and autoimmune diseases, also rare illnesses that only distress a very small number of patients. Subsequently, numerous global drug manufacturers are presently concentrating on the growth of novel formulations and have sub contracted their closing, filling, and packing tasks of leading products to contract manufacturers, which are founded in the markets such as India and China. All manufacturers need extremely flexible equipment that can adjust to new-fangled products and packing formats rapidly.

Snowballing strict quality necessities and subcontracting of pharmaceutical packaging to contract packagers in emergent nations are anticipated to support the market during years to come. Pharmaceutical players are subcontracting the packaging operations to contract packagers to decrease the total speed and cost of production to market. This is predicted to subsidize to the market expansion during next few years. Additionally, deficiency of in-house packaging competences, proficiency, and budget restrictions are the few crucial problems confronted by small pharmaceutical firms in the market. Contract packaging service providers are considered as an operative way to limit such problems of the small companies due to the affordable service offering. Deficiency of resources and finances has encouraged several small pharmaceutical players to recognized mutually advantageous associations with CDMOs and CPOs.

Regional Snapshots:

North America dominates the global in pharmaceutical contract packaging marketplace on account of U.S. been global front-runner in drug manufacturing for numerous diseases. Asia Pacific is probable to eyewitness the rapid over next few years because of the occurrence of a great number of contract packaging service providers in the region. These companies are concentrating on escalating their services to cater the rising requirements of pharmaceuticals players. Further, snowballing the subcontracting pharmaceutical packaging to developing nations like India is further thriving the growth of the market in the APAC.

Escalating health awareness and swelling stress on the pharma players for reduction of the cost is added reason to further reinforce the growth of the pharmaceutical contract packaging market. Pharmaceutical drugs such as allopathic, antibiotic and alternative have huge request from consumers from APEJ nations. The development of pharmaceutical players in APEJ region will lift the market of pharmaceutical contract packaging as most of these players doesn’t engross itself in packing and wrapping of medicine. Western Europe nations including France, Germany, and U.K. are also progressing with a decent speed towards pharmaceutical contract packaging to curb added operational expenditures of packaging for pharmaceutical firms.

Report Highlights:

  • Asia Pacific expected to record fastest growth rate due to the intensifying requirement for medicines amongst COVID-19 epidemic and snowballing dependence on contract manufacturing organizations owed to better-quality competence and output
  • The primary packaging segment grasp the major market revenue share due to the upsurge in sub-contracting of primary wrapping tasks to CPOs
  • The glass segment held the considerable revenue share of more than 35% in 2019 owing to mid-sized and small pharmaceutical companies who do not possess glass wrapping abilities
  • North America hit largest revenue share of the global pharmaceutical contract packaging market in 2019

Key Players & Strategies:

Some of the chief players involved in the contract pharmaceutical packaging are Becton, Dickinson and Co., AmerisourceBergen Corp., and Berlin Packaging. Few other players operating in the pharmaceutical contract packaging market arena are SCHOTT AG, Amcor plc., Bosch Packaging Technology GmbH., , Catalent, Inc., KlöcknerPentaplast, Gerresheimer AG, Bausch+Ströbel, AptarGroup, Inc., Wipak Oy, WestRock CompanyRobert DuPont de Nemours, Inc., among other local and international player.

Though the snowballing number of new drug approvals by the FDA will offer enormous growth openings, the appearance of in-house packaging will challenge the progress of the market players. To make the most of the prospects, market players should emphasis more on the development outlook in the strong-growing segments, whereas upholding their foothold in the slow-growing market segments.

Market Segmentation:

By Product

  • Primary Packaging
    • Ampoules
    • Bottles
    • Blister Packs
    • Others
  • Secondary Packaging
  • Tertiary Packaging

By Material

  • Paper & Paperboard
  • Plastics & Polymers
  • Aluminium Foil
  • Glass
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada    
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • South Africa
    • North Africa
    • Rest of Middle East & Africa

[email protected] https://www.precedenceresearch.com/pharmaceutical-contract-packaging-market


Join the discussion Sign In or Become a Member, doing so is simple and free